Non-canonical NFκB activation promotes chemokine expression in podocytes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Valino Rivas, Lara ^a,b   Gonzalez Lafuente, Laura ^a,b   Sanz, Ana B ^a,b   Ruiz Ortega, Marta ^a,b   Ortiz, Alberto ^a,b   Sanchez Nino, Maria D ^a,b  

^a Section of Nephrology   (Spain)

^b REDINREN ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CCL19 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; TNFSF12 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 12;

ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHRONIC KIDNEY FAILURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NUCLEOCYTOPLASMIC TRANSPORT; PODOCYTE; PROTEIN PROCESSING; PROTEINURIA; SIGNAL TRANSDUCTION; WISTAR KYOTO RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; CHEMOKINE CCL5; CYTOKINE TWEAK; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICE; NF-KAPPA B; PODOCYTES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINURIA; RATS, INBRED WKY; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 84976604624     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28857     Document Type: Article

References (43)

1. Ortiz, A. et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383, 1831-1843 (2014).
2. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117-171 (2015).
3. Fernandez-Fernandez, B., Ortiz, A., Gomez-Guerrero, C., Egido, J. Therapeutic approaches to diabetic nephropathy-beyond the RAS. Nat. Rev. Nephrol. 10, 325-346 (2014).
4. Sanz, A. B. et al. TWEAK and the progression of renal disease: clinical translation. Nephrol. Dial. Transplant. 29 Suppl. 1, i54-i62 (2014).
5. Xia, Y. et al. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J. Am. Soc. Nephrol. 26, 1053-1070 (2015).
6. Xia, Y. et al. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin. Immunol. 145, 108-121 (2012).
7. Zhao, Z. et al. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J. Immunol. 179, 7949-7958 (2007).
8. Sanchez-Nino, M. D. et al. Fn14 in podocytes and proteinuric kidney disease. Biochim. Biophys. Acta 1832, 2232-2243 (2013).
9. Sasaki, Y., Shimizu, Y., Suzuki, Y., Horikoshi, S., Tomino, Y. TWEAK/Fn14 system and crescent formation in IgA nephropathy. BMC. Nephrol. 16, 27 (2015).
10. Anderberg, R. J. et al. Serum amyloid A and inflammation in diabetic kidney disease and podocytes. Lab Invest 95, 250-262 (2015).
11. El, M. F., Keuylian, Z., Kavvadas, P., Dussaule, J. C., Chatziantoniou, C. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J. Am. Soc. Nephrol. 26, 1561-1575 (2015).
12. Kuravi, S. J. et al. Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk. J. Immunol. 193, 234-243 (2014).
13. Sanz, A. B. et al. NF-kappaB in renal inflammation. J. Am. Soc. Nephrol. 21, 1254-1262 (2010).
14. Poveda, J. et al. TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease. Front Immunol. 4, 447 (2013).
15. Sanz, A. B. et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J. Am. Soc. Nephrol. 19, 695-703 (2008).
16. Berzal, S. et al. TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-kappaB pathway and ERK activation. J. Cell Physiol 230, 1580-1593 (2015).
17. Sanz, A. B. et al. TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS One. 5, e8955 (2010).
18. Lo, J. C. et al. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J. Clin. Invest 112, 1495-1505 (2003).
19. Banas, B. et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J. Immunol. 168, 4301-4307 (2002).
20. Banas, B. et al. Binding of the chemokine SLC/CCL21 to its receptor CCR7 increases adhesive properties of human mesangial cells. Kidney Int. 66, 2256-2263 (2004).
21. Wornle, M., Schmid, H., Merkle, M., Banas, B. Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC. Nephrol. 5, 8 (2004).
22. Zhou, H. L., Wang, Y. T., Gao, T., Wang, W. G., Wang, Y. S. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts. Transplant. Proc. 45, 538-545 (2013).
23. Kotsch, K. et al. Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome. Transplantation 90, 958-965 (2010).
24. Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603-612 (2004).
25. Sakai, N. et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl. Acad. Sci. USA 103, 14098-14103 (2006).
26. Dejardin, E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179 (2006).
27. Bonizzi, G. et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23, 4202-4210 (2004).
28. Hehner, S. P., Hofmann, T. G., Droge, W., Schmitz, M. L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NFkappa B by targeting the I kappa B kinase complex. J. Immunol. 163, 5617-5623 (1999).
29. Gomez-Chiarri, M. et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70, 449-459 (1994).
30. Ortiz, A. et al. Translational value of animal models of kidney failure. Eur. J. Pharmacol. 759, 205-220 (2015).
31. Gao, H. X. et al. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 46, 24-35 (2009).
32. Ruiz-Ortega, M., Ortiz, A., Ramos, A. M. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease. Curr. Opin. Nephrol. Hypertens. 23, 93-100 (2014).
33. Dejardin, E. et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 17, 525-535 (2002).
34. Saitoh, T. et al. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J. Biol. Chem. 278, 36005-36012 (2003).
35. Sanchez-Sanchez, N., Riol-Blanco, L., Rodriguez-Fernandez, J. L. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176, 5153-5159 (2006).
36. Reich, H. N. et al. A molecular signature of proteinuria in glomerulonephritis. PLoS. One. 5, e13451 (2010).
37. Hodgin, J. B. et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am. J. Pathol. 177, 1674-1686 (2010).
38. Berthier, C. C. et al. Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J. Immunol. 189, 988-1001 (2012).
39. Woroniecka, K. I. et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 60, 2354-2369 (2011).
40. Mundel, P., Kriz, W. Cell culture of podocytes. Exp. Nephrol. 4, 263-266 (1996).
41. Sanchez-Nino, M. D. et al. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest 92, 32-45 (2012).
42. Sanchez-Nino, M. D. et al. Albumin-induced apoptosis of tubular cells is modulated by BASP1. Cell Death. Dis. 6, e1644 (2015).
43. Husi, H. et al. A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC. Syst. Biol. 7, 110 (2013).